Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
4DMedical Ltd ( (AU:4DX) ) has provided an announcement.
4DMedical has entered a commercial agreement with Qscan Radiology Clinics after a successful pilot, marking its first Australian contract to incorporate both its Pulmonary Function and Pulmonary Structure suites. This agreement will allow Qscan to offer 4DMedical’s advanced respiratory imaging solutions at select practices, expanding the availability of their cutting-edge technology across Australia and supporting improved healthcare outcomes.
More about 4DMedical Ltd
4DMedical Limited (ASX:4DX) is a global leader in medical technology, focused on revolutionizing respiratory care through advanced imaging and AI-powered solutions. Their patented XV Technology® enables precise analysis of lung function, aiding in the early diagnosis of respiratory diseases. The company integrates its solutions seamlessly into existing hospital infrastructures, enhancing diagnostic capabilities through a Software as a Service model.
YTD Price Performance: 18.75%
Average Trading Volume: 838,582
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$236M
Find detailed analytics on 4DX stock on TipRanks’ Stock Analysis page.
